Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Category:

Investing

  • Investing

    Opawica Announces the Closing of Non-Brokered Private Placement

    by admin December 21, 2024
    December 21, 2024

    (TheNewswire) December 20th, 2024 Vancouver, B.C. TheNewswire – Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD)…

  • Investing

    Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

    by admin December 21, 2024
    December 21, 2024

    The S&P/TSX Venture Composite Index (INDEXTSI:JX) fell 2.87 percent on the week to close at…

  • Investing

    Hempalta Corp. Announces Financial Results for Year Ended September 30, 2024

    by admin December 20, 2024
    December 20, 2024

    AgTech Company highlights recent 100% purchase of Hemp Carbon Standard platform to advance industrial hemp…

  • Investing

    Forum Comments on Share Price

    by admin December 20, 2024
    December 20, 2024

    Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) (‘Forum’ or the ‘Company’) announced today that…

  • Investing

    Opawica Explorations Inc Begins Field Work in Preparation of Upcoming Drill Campaign at Its Bazooka Property in the Abitibi Gold Belt

    by admin December 20, 2024
    December 20, 2024

    (TheNewswire) December 19th, 2024 TheNewswire – Vancouver, B.C. Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD)…

  • Investing

    Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

    by admin December 20, 2024
    December 20, 2024

    Westgold Resources (ASX:WGX,TSX:WGX,OTCQX:WGXRF) has completed a scoping study that evaluates an expansion of its Fortnum…

  • Investing

    RAD 202 receives approval to start Phase 1 therapeutic trial

    by admin December 20, 2024
    December 20, 2024

    Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial…

  • Investing

    PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

    by admin December 20, 2024
    December 20, 2024

    Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative…

  • Investing

    Completion of Tranche 1 of the Placement

    by admin December 20, 2024
    December 20, 2024

    Cyprium Metals Limited (ASX: CYM, OTC: CYPMF) (Cyprium or the Company) is pleased to announce…

  • Investing

    5 Best-performing Canadian Nickel Stocks of 2024

    by admin December 20, 2024
    December 20, 2024

    After trending down in 2023, nickel prices climbed to a 10 month high in late…

Newer Posts
Older Posts

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024
    • 4

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 5

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024

    Categories

    • Investing (3,716)
    • Latest News (2,300)
    • Politics (4,504)
    • Stocks (1,328)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved